China's Supreme People's Court has issued a landmark ruling on employee invention remuneration, establishing that payment is contingent upon the invention generating actual economic benefits after implementation. The case involved a dispute between a former senior director and his employer over compensation for a pharmaceutical patent, with the court clarifying calculation methods, contribution rates, and the burden of proof in such disputes.